CNTX

Conviction 10HealthcareScan · Mon, Aug 10, 2026

CNTX$0.4528-6.45%

ResistanceSupportVol 14

Vol MA14 1.95M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Context Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.contexttherapeutics.com ↗

Price0.4528

Change-6.45%

Gap+0.52%

Rel volume1.30×

Avg volume1.73M

Avg $ vol1.01M

SMA 200.5965

SMA 500.9013

SMA 2001.71

Price vs 50-49.76%

Price vs 200-73.45%

MA stackbearish

50/200 cross—

Supertrenddown · 0.6590

RSI (14)30

MACD hist0.01

MACD cross—

Stoch %K / %D7 / 5

ADX (14)36

+DI / −DI15 / 35

RSI divergenceBullish

MACD divergenceBearish

ATR %+15.83%

ADR %7.40%

52w high3.36

52w low0.4528

From 52w high-86.52%

Above 52w low+0.00%

New 52w highNo

SqueezeOn · 12d

Bollinger width35.93%

%B-0.17

Donchian pos6.74%

Donchian high0.6949

Donchian low0.4353

AVWAP (52w high)1.12

vs AVWAP high-59.51%

AVWAP (52w low)0.4582

vs AVWAP low-1.18%

OBV trendDown

Chaikin MF (20)-0.07

Today vs 20d1.30×

Avg vol (14d)1.95M

Avg vol (20d)1.73M

Avg $ vol (20d)1.01M

Market cap41.6M

RS 3m (vs SPY)-84.92%

RS 6m (vs SPY)-92.70%

RS line new highNo

Trend template1/8

Technical rank1.7

1 week-25.05%

1 month-30.65%

3 months-80.97%

6 months-80.14%

1 year-35.22%

YTD-70.79%

P/E-1.15

P/B1.09

P/S—

P/FCF-1.57

EPS-0.3800

Div yield—

ROE-94.63%

ROA-78.30%

Debt/Eq—

Current5.81

EV/EBITDA0.04

Gross margin—

Net margin—

Rev growth—

EPS growth-35.17%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-1.39M

Revenue—

Net income-14.56M

Gross profit—

Free cash flow-26.42M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out91.88M

Employees15

ListedWed, Oct 20, 2021

Free float67.49M

Float %73.5%

Short interest6.63M

Days to cover1.8d

Short volume50.2%

Squeeze score40 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction10 / 100

Pattern quality—

Tech rank1.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.6986

Support0.5475

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CNTX

All disclosures →

No recent disclosed trades by Congress in CNTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CNTX · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Kantoff Philip W. Director · Stock Option (right to buy) · 2026-06-24	Grant	45K	—	2026-06-24	2026-06-26
Walker Luke Nathaniel Director · Stock Option (right to buy) · 2026-06-24	Grant	45K	—	2026-06-24	2026-06-26
Smith Karen L. Director · Stock Option (right to buy) · 2026-06-24	Grant	45K	—	2026-06-24	2026-06-26
West Linda Director · Stock Option (right to buy) · 2026-06-24	Grant	45K	—	2026-06-24	2026-06-26
Stacey Jennifer Evans Director · Stock Option (right to buy) · 2026-06-24	Grant	45K	—	2026-06-24	2026-06-26
Pasternak Andy Director · Stock Option (right to buy) · 2026-06-24	Grant	45K	—	2026-06-24	2026-06-26

SEC filings

EDGAR filings in CNTX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.